Purpose: We developed and validated a Prostate Health Index (Beckman Coulter, Brea,
California) based nomogram to predict prostate cancer at extended prostate biopsy …

Background External validation of a prediction tool is mandatory to assess the tool's
accuracy and generalizability within different patient cohorts. Objective To externally validate …

To develop and externally validate a prostate health index (PHI)-based nomogram for
predicting the presence of prostate cancer (PCa) at biopsy in Chinese men with prostate …

OBJECTIVES To develop a logistic regression‐based model to predict prostate cancer
biopsy at, and compare its performance to the risk calculator developed by the Prostate …

Purpose: We developed and validated a nomogram which predicts presence of prostate
cancer (PCa) on needle biopsy. Materials and Methods: We used 3 cohorts of men who …

OBJECTIVES: To construct a nomogram that can be used to estimate the risk of prostate
cancer (PCa) and high-grade PCa using readily available clinical information for men …

Study Type–Diagnosis (exploratory cohort) Level of Evidence 2b What's known on the
subject? and What does the study add? In recent years, several nomograms were …

Background There is a large amount of confusion in interpreting prostate specific antigen
(PSA) values for prostate cancer. More precise risk assessments for prostate cancer …

Purpose: We developed a predictive model that incorporates clinical data and prostate
specific antigen kinetic from general practice to detect prostate cancer in patients with a …

OBJECTIVES: To develop a model capable of predicting prostate biopsy outcomes in a
large screening population, with independent validation in the referral setting. METHODS …